https://www.selleckchem.com/products/kn-93.html
ificant differences were detected in the improvements of BCVA or CRT and injection numbers between the IVR and IVA groups treated with the TAE regimen. These results indicate that the results of the treatment with both agents with the TAE regimen were equally effective, but only 20.8% of patients completed 24 months of continuous treatment with the TAE regimen. Synopsis There are no significant differences regarding effectiveness between the IVR and IVA groups treated with the TAE regimen for DME eyes.Risperidone (RSP) is an atypical anti